Ami Organics IPO details (1 – 3 Sep), (Price: ₹ 603 – 610)
Listing date and Listing Price of Ami Organics IPO:
- Ami Organics IPO listed on BSE and NSE exchanges on – Click Here
- Listing Price of Ami Organics IPO on NSE – Click Here
- Listing Price of Ami Organics IPO on BSE – Click Here
Grey Market premium (GMP) price of Ami Organics IPO :
Grey Market premium (GMP) price of Ami Organics IPO is Rs. 0. Grey Market premium (GMP) of Ami Organics IPO means, unofficially if someone buys or sells his application at a fixed rate irrespective of listing price. Check latest GMP of all IPOs.
Ami Organics IPO Allotment link status on Link Intime:
- Check the allotment status of Ami Organics IPO on the below link given by Link Intime.
- Ami Organics IPO Allotment Link – https://linkintime.co.in/MIPO/Ipoallotment.html
Ami Organics IPO Allotment link status on Link Intime can be checked by Application No or DP Client ID or PAN.
Ami Organics IPO subscription status details:
|QIB (Qualified Institl. Bidders)||NIB (Non-institutional Investor)||RII (Retail Individual Investor)||Total No. of times applied|
Ami Organics IPO highlights:
|Ami Organics IPO bid Opens on||1 Sep 2021|
|Ami Organics IPO bid Closes on||3 Sep 2021|
|Post issue Modification Period||4- Sep-2021 (10.00 A.M. to 11.00 A.M.)|
|Cut-off time for UPI Mandate Confirmation||4- Sep-2021 (upto 12:00 PM)|
|Issue type||100% Book Building|
|Ami Organics IPO issue size||₹ 569.64 Cr|
|Face value of each equity share||Rs. 10|
|Ami Organics IPO Price band||Rs. 603 to Rs. 610 per share|
|Ami Organics IPO market lot||24 equity shares and multiples of 24|
|Ami Organics IPO minimum order quantity||24 equity shares|
|Pre IPO equity share of promoters of Ami Organics||47.23 %|
|Post IPO paid-up equity share of promoters of Ami Organics||41.05 %|
|QIB portion reservation in Ami Organics IPO||50 %|
|NIB portion reservation in Ami Organics IPO||15 %|
|Retail portion reservation in Ami Organics IPO||35 %|
|Retail individual bidder can apply in Ami Organics IPO||up to 2 lakh (200,000) – Maximum 13 Lot|
|Retail individual discount in Ami Organics IPO||NA|
|Employees can apply in Ami Organics IPO||up to 5 lakh (500,000)|
|Employees Reservation in Ami Organics IPO||NA|
|Employees Discount in Ami Organics IPO||NA|
|Listing of Ami Organics at Exchanges||NSE, BSE|
|Fund raised from Anchor Investors in Pre-IPO of Ami Organics||NA|
|Registrar of Ami Organics IPO issue||Link Intime India Private Limited|
Ami Organics IPO important dates regarding bidding, allotment, listing, refund etc. :
The probable dates regarding bidding, allotment, listing, refund of Ami Organics IPO are mentioned below.
|Ami Organics IPO opens on||01.09.2021|
|Ami Organics IPO Closes on||03.09.2021|
|Allotment basis date of Ami Organics IPO||08.09.2021|
|Money refund date of Ami Organics IPO||09.09.2021|
|Shares of Ami Organics in Demat Account||13.09.2021|
|Ami Organics IPO listing date on NSE, BSE||14.09.2021|
How much shares of Ami Organics IPO are being offered?
|Type of Issue (Fresh / OFS)||No. of Equity shares offered||Amount of Equity shares|
|Total Issue size||₹ 569.64 Crore|
|Fresh Issue size||–||₹ 200 Crore|
|Offer for Sale (OFS)||–||₹ 369.64 Crore|
Ami Organics financial statements details:
|(₹ million)||(₹ million)||(₹ million)|
|Profit After Tax||539.99||274.7||232.95|
IPO Red Herring Prospectus (RHP) of Ami Organics:
Objectives of the Ami Organics IPO Issue: (Source – RHP)
The net proceeds of the Fresh Issue, i.e., Gross proceeds of the Fresh Issue less the Offer expenses apportioned to our Company (“Net Proceeds”) and the proceeds from the Pre-IPO Placement are proposed to be utilised in the following manner: 1. Repayment/prepayment of certain financial facilities availed by our Company; 2. Funding working capital requirements of our Company; and 3. General corporate purposes.
Business of Ami Organics: (Source – RHP)
We are a research and development (“R&D”) driven manufacturer of specialty chemicals with varied end usage, focussed towards the development and manufacturing of advanced pharmaceutical intermediates (“Pharma Intermediates”) for regulated and generic active pharmaceutical ingredients (“APIs”) and New Chemical Entities (“NCE”) and key starting material for agrochemical and fine chemicals, especially from our recent acquisition of the business of Gujarat Organics Limited (“GOL”)(“Acquisition”).
As per the F&S Report, we are one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. The Pharma Intermediates which we manufacture, find application in certain high-growth therapeutic areas including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant and anti-coagulant, commanding significant market share both in India and globally.
Go Back to – IPO Dashboard for other IPOs:
Disclaimer: Kindly verify from RHP and concerned company for any clarification.
If you liked this article, kindly share it on any platform, whatsapp, facebook, twitter, Linkedin etc. below to keep us motivated.